Latest Regulatory Milestones News

Argosy Minerals Limited has launched a $2 million placement accompanied by an offer of up to 40 million options, aiming to bolster development and feasibility efforts at its Rincon Lithium Project in the USA.

EVE Health Group has secured regulatory approval enabling prescription access for its lead products Libbo and Dyspro in Australia, setting the stage for a commercial rollout before the end of 2025.

Elixir Energy has advanced its strategic plan in Queensland’s Taroom Trough, appointing a new COO, initiating a major cost reduction, and preparing to drill key exploration and appraisal wells that could unlock significant gas resources.

Lumos Diagnostics reported a 12% revenue increase for FY25 and inked a landmark US$317 million exclusive distribution deal for its FebriDx test, while advancing its FDA CLIA waiver application.

Macro Metals Limited is poised to resume trading on the ASX from July 18, 2025, following a key Supreme Court decision. The lifting of its trading suspension marks a significant regulatory milestone for the mining company.

Lumos Diagnostics has locked in a A$5 million secured loan facility to support working capital as it advances toward FDA CLIA waiver for its FebriDx® test, complementing a landmark US distribution deal.

Lumos Diagnostics has inked a landmark six-year exclusive distribution agreement with PHASE Scientific for its FebriDx® rapid diagnostic test in the US, potentially unlocking nearly half a billion Australian dollars in revenue contingent on FDA approval.

Wia Gold Limited has significantly upgraded its Kokoseb Gold Project resource to 2.93 million ounces, advancing steadily toward a Definitive Feasibility Study targeted for late 2026. The company’s accelerated drilling and strong high-grade results underpin its ambition to become Namibia’s fourth commercial gold mine.

DP World Australia has secured Foreign Investment Review Board approval to acquire 100% of Silk Logistics, clearing a major regulatory hurdle for the deal.

High-Tech Metals has obtained crucial mining approvals and formed a joint venture to tap into historic gold stockpiles at its Mt Fisher Project, aiming for early cash flow and resource definition.

Imagion Biosystems has received encouraging feedback from the FDA on its MagSense HER2 breast cancer imaging program, clearing the path for a Phase 2 clinical trial and fast-tracking manufacturing.

EBR Systems has received preliminary approval from the U.S. Centers for Medicare & Medicaid Services for outpatient reimbursement of its WiSE® CRT System, marking a major step toward broader hospital adoption.